BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 9334327)

  • 1. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.
    Cujec TP; Okamoto H; Fujinaga K; Meyer J; Chamberlin H; Morgan DO; Peterlin BM
    Genes Dev; 1997 Oct; 11(20):2645-57. PubMed ID: 9334327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
    Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
    Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.
    Chen D; Zhou Q
    Mol Cell Biol; 1999 Apr; 19(4):2863-71. PubMed ID: 10082552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity.
    Nekhai S; Shukla RR; Kumar A
    J Virol; 1997 Oct; 71(10):7436-41. PubMed ID: 9311822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
    Isel C; Karn J
    J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
    Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
    Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
    Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
    Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
    Parada CA; Roeder RG
    Nature; 1996 Nov; 384(6607):375-8. PubMed ID: 8934526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.
    García-Martínez LF; Mavankal G; Neveu JM; Lane WS; Ivanov D; Gaynor RB
    EMBO J; 1997 May; 16(10):2836-50. PubMed ID: 9184228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
    Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
    J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CDK7 substrate specificity by MAT1 and TFIIH.
    Yankulov KY; Bentley DL
    EMBO J; 1997 Apr; 16(7):1638-46. PubMed ID: 9130709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
    Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
    J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
    Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
    Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.
    Rossignol M; Kolb-Cheynel I; Egly JM
    EMBO J; 1997 Apr; 16(7):1628-37. PubMed ID: 9130708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cdk-activating kinase subunits with transcription factor TFIIH.
    Serizawa H; Mäkelä TP; Conaway JW; Conaway RC; Weinberg RA; Young RA
    Nature; 1995 Mar; 374(6519):280-2. PubMed ID: 7885450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk-activating kinase complex is a component of human transcription factor TFIIH.
    Shiekhattar R; Mermelstein F; Fisher RP; Drapkin R; Dynlacht B; Wessling HC; Morgan DO; Reinberg D
    Nature; 1995 Mar; 374(6519):283-7. PubMed ID: 7533895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors.
    Inamoto S; Segil N; Pan ZQ; Kimura M; Roeder RG
    J Biol Chem; 1997 Nov; 272(47):29852-8. PubMed ID: 9368058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
    Hoque M; Young TM; Lee CG; Serrero G; Mathews MB; Pe'ery T
    Mol Cell Biol; 2003 Mar; 23(5):1688-702. PubMed ID: 12588988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CAK kinase activity by p53.
    Schneider E; Montenarh M; Wagner P
    Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH.
    Serizawa H
    J Biol Chem; 1998 Mar; 273(10):5427-30. PubMed ID: 9488660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.